Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with neurofibromatosis type 1 [ID6385]

  • Awaiting development
  • GID-TA11457
  • Expected publication date: TBC

33516-Selumetinib-for-Plexiform-Neurofibromas-V1.0-SEP2023-NON-CONF.pdf (nihr.ac.uk)